Phase 1 Serum Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Not Yet Recruiting
Phase 1
A Phase 1, Partially Blinded, Placebo-Controlled, Pharmacokinetic Study of Intravenously Administered BMS-943539-01-001 in Healthy Male Volunteers
Pharmacokinetics of Intravenously Administered BMS-943539 in Healthy Male Volunteers.
BMS-943539 is an Adnectin (protein) which is specifically engineered to bind to Human Serum Albumin (HSA).
Bristol-Myers Squibb Australia37 enrolled1 locationACTRN12610001043022
Recruiting
Phase 1
A prospective Randomised Controlled Trial assessing recombinant Luteinising Hormone supplementation in patients with a relative reduction in Luteinising Hormone (LH) levels during Vitro Fertilisation/Intracytoplasmic sperm Injection (IVF/ICSI) treatment.
Low serum LH levels during IVF treatment cycles.Infertility treated with IVF
IVFAustralia697 enrolled1 locationACTRN12610000064000
Completed
Phase 1
A phase I pharmacokinetic study to compare the steady-state pharmacokinetics of testosterone following application of a Testosterone Metered-Dose Transdermal Spray (MDTS) to the forearm or abdomen in healthy postmenopausal women with low libido and low serum testosterone
Low libido in post-menopausal women with low serum testosterone
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd14 enrolled1 locationACTRN12605000522617